- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02044783
Identifying and Treating Physical Function Impairment in Elders
Sedentary older adults are more likely to develop physical function impairments than active older adults. Physical function measured by slow usual gait speed predicts the risk of future falls, disability, institutionalization and mortality. Behavioral physical activity interventions have improved physical activity and physical function, but have not generally been implemented where they may have the most impact -- primary care settings. In part, this is due to the limited time and training for clinical staff to screen for physical function impairment and to treat with physical activity counseling. The proposed scientific goal is to overcome these barriers by adapting an evidence-based screening tool and telephone-based physical activity intervention into primary care settings.
Aim1: Among older adults who screen positive for physical function impairment, to determine the estimated intervention effect size of a 12-week behavioral intervention on physical activity and physical function.
Hypothesis 1a: Physical activity levels will increase more in the intervention vs. usual care group.
Hypothesis 1b: Physical function will increase more in the intervention vs. usual care group.
Aim 2: Among Aim 1 participants and clinical staff who deliver the functional screening and Aim 1 intervention, to evaluate standard implementation science process metrics of reach, acceptability, and implementation
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Colorado
-
Aurora, Colorado, Stati Uniti, 80045
- University of Colorado Anschutz Medical Campus
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Sedentary patients aged 65-85 years who screen positive for physical function impairment (Physical function impairment includes any of the following: time to complete 4-meter walk ≥4.82 seconds (i.e., ≥0.83 meters/second); a reported fall in the past 3 months; or a reported fear of falling)
Exclusion Criteria:
- Inability to walk ≥30 feet without human assistance7
- Dementia, as assessed by either a Folstein Mini-Mental Status Examination <24 or by patient's primary care provider's assessment
- Severe vision loss (legally blind)
- Severe hearing loss
- Medical condition that precludes increasing physical activity per primary care provider's assessment
- Terminal diagnosis per primary care provider's assessment
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Behavioral Intervention
Behavioral Counseling Intervention: 6 telephone calls that include physical activity goal-setting, tracking,and problem-solving of barriers
|
|
|
Nessun intervento: Usual Care
Monthly mailed print materials on aging topics (that would generally be administered by subjects' primary care clinic).
No behavioral counseling.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes in physical activity as determined by accelerometer
Lasso di tempo: 12 weeks
|
Subjects' physical activity levels will be determined by accelerometer measures during week 1 and after a 12-week behavioral intervention.
|
12 weeks
|
|
Changes in physical function as assessed by 400-meter walk speed
Lasso di tempo: 12 weeks
|
Subjects' physical function will be assessed by 400-meter walk speed before and after 12-week behavioral intervention.
|
12 weeks
|
|
Changes in physical function as assessed by Short Physical Performance Battery
Lasso di tempo: 12 weeks
|
Subjects' physical function will be assessed by the Short Physical Performance Battery before and after a 12-week intervention
|
12 weeks
|
|
Change in physical function as assessed by lower extremity strength testing
Lasso di tempo: 12 weeks
|
Subjects' physical function will be assessed by lower extremity strength testing before and after a 12-week behavioral intervention .
|
12 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Evaluation of standard implementation science process of reach
Lasso di tempo: 1 year
|
Reach is the percent of patients consented divided by the number eligible.
|
1 year
|
|
Assessment of standard implementation science process metrics of acceptability
Lasso di tempo: 1 year
|
Acceptability will be assessed through structured surveys.
|
1 year
|
|
Assessment of standard implementation science process metrics of implementation
Lasso di tempo: 1 year
|
Implementation process will be assessed by structured surveys
|
1 year
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Amy Huebschmann, MD, University of Colorado - Anschutz Medical Campus
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Consulenza comportamentale
-
Square2 Systems, Inc.National Institute on Drug Abuse (NIDA)Attivo, non reclutanteDisturbi Correlati a Sostanze | Disturbi da Uso di SostanzeStati Uniti
-
University of PittsburghCompletatoDistrofia muscolare di DuchenneStati Uniti
-
Sarah MorrowLawson Health Research InstituteCompletato
-
Assuta Hospital SystemsTel Aviv UniversityCompletato
-
Duke UniversityCompletatoCessazione dell'uso del tabaccoStati Uniti
-
Weill Medical College of Cornell UniversityReclutamentoDepressione perinatale | Ansia perinataleStati Uniti
-
Pakistan Institute of Medical SciencesReclutamentoContraccezionePakistan
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletatoFemmina di cancro al seno
-
TC Erciyes UniversityThe Scientific and Technological Research Council of TurkeyCompletatoTinnito cronicoTurchia (Türkiye)
-
Centers for Disease Control and PreventionState University of New York - Downstate Medical CenterCompletatoClamidia Trachomatis | Neisseria gonorrhoeaeStati Uniti